+184.2%
SLV vs EMR
+63.5%
+120.7%
-52.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | +1.7% | -2.9% | -1.8% |
| 7D | -0.3% | -1.5% | +1.2% | +0.2% |
| 30D | +6.7% | -5.6% | +12.3% | +8.9% |
| 3M | -10.7% | +7.9% | -18.6% | -13.2% |
| 6M | -20.6% | +6.0% | -26.6% | -22.8% |
| YTD | -7.1% | +16.4% | -23.6% | -10.4% |
| 1Y | +62.0% | +16.6% | +45.4% | +56.0% |
| All | +184.2% | +63.5% | +120.7% | +152.3% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling